<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="109075">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01663064</url>
  </required_header>
  <id_info>
    <org_study_id>11-018</org_study_id>
    <nct_id>NCT01663064</nct_id>
  </id_info>
  <brief_title>Zenith® p-Branch™: Single-Center Study</brief_title>
  <acronym>PBCT</acronym>
  <official_title>Zenith® p-Branch™: Single-Center Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cook</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cook</source>
  <oversight_info>
    <authority>Sweden: Medical Products Agency</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Zenith® p-Branch™: Single-Center Study is a clinical trial approved by Swedish
      Regulatory Authority to study the safety and effectiveness of the Zenith® p-Branch™ in the
      treatment of abdominal aortic aneurysms.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Technical Success</measure>
    <time_frame>Up to 5 years</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Technical success is described as: 1) successful access of the aneurysm site, 2) successful deployment of the Zenith® p-Branch™ endovascular graft in the intended location, 3) Zenith® p-Branch-™ endovascular graft is patent at deployment completion as evidenced by intraoperative angiography, and 4) all vessels targeted with a fenestration are patent at deployment completion as evidenced by intraoperative angiography.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Aortic Aneurysm</condition>
  <condition>Abdominal Aortic Aneurysm</condition>
  <arm_group>
    <arm_group_label>Endovascular</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endovascular treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endovascular treatment (Zenith® p-Branch™ endovascular graft)</intervention_name>
    <description>Instead of making a large incision in the chest, the physician makes a small incision near each hip to insert, and guides the study device(s) into place in the aorta.</description>
    <arm_group_label>Endovascular</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pararenal or juxtarenal AAA &gt;5.0 cm in  diameter

          -  Pararenal or juxtarenal AAA with history of growth &gt;0.5 cm/year

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Life expectancy &lt; 2 years

          -  Pregnant or breast feeding

          -  Inability or refusal to give informed consent by the patient or a legally authorized
             representative

          -  Unwilling or unable to comply with the follow-up schedule

          -  Additional medical restrictions as specified in the Clinical Investigation Plan

          -  Additional anatomical restrictions as specified in the Clinical Investigation Plan
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timothy A. Resch, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Skane University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Trine Toelboell, DVM, PhD</last_name>
    <phone>+45 56868971</phone>
    <email>Trine.Toelboell@CookMedical.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Skane University Hospital</name>
      <address>
        <city>Malmo</city>
        <zip>SE-205 02</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Timothy A. Resch, MD, PhD</last_name>
      <phone>+46 40331000</phone>
      <email>timothyresch@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 3, 2014</lastchanged_date>
  <firstreceived_date>August 2, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Abdominal aortic aneurysm</keyword>
  <keyword>Endovascular</keyword>
  <keyword>Fenestration</keyword>
  <keyword>Juxtarenal</keyword>
  <keyword>Off-the-shelf</keyword>
  <keyword>Pararenal</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
